home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Leaders in Biobanking Congress 2014

 
  April 09, 2014  
     
 
Sheraton Seattle Hotel, 1400 6th Avenue, Seattle, WA 98101, USA
September 15-17, 2014


Today, biospecimen collections are used by multiple research groups for varying research aims, from basic research through clinical trials. A well-managed biobank is a critical prerequisite for high-quality biological research. The proper collection, processing, storage and tracking of biospecimens are critical components allowing researchers to better link molecular and clinical information. Thus, by necessity, biobanking is both a science and a business. Cambridge Healthtech Institute's Sixth Annual Leaders in Biobanking Congress: Maximizing Your Investment in Biospecimens addresses both the business and science of biobanking, bringing together biomedical and biopharmaceutical researchers, regulators, biorepository managers and practitioners to investigate the best strategies for effective use of biospecimens within today's cutting-edge research.
 
 
Organized by: Cambridge Healthtech Institute (CHI)
Invited Speakers:
  • John T. Slattery, Ph.D., Vice Dean, Research and Graduate Education, School of Medicine; Professor, Pharmacology and Medicine, University of Washington School of Medicine
  • Nathan D. Price, Ph.D., Associate Director, Institute for Systems Biology
  • James M. Olson, M.D., Ph.D., Member, Clinical Research Division, Fred Hutchinson Cancer Research Center; Professor, Pediatric Hematology and Oncology, University of Washington; Attending Physician, Seattle Children’s Hospital; Founder, Presage Biosciences
  • Carolyn Compton, M.D., Ph.D., CMO, National Biomarkers Development Alliance; Professor, School of Life Sciences, Arizona State University
  • Devon D. Kelly, Director, OHSU Knight BioLibrary, Oregon Health & Science University, Knight Cancer Institute
  • Stephanie Elaine Soares, MS, CCRP, Research Administrator, Urology, University of California, Davis
  • Shannon Sewards, Associate Director, Human Subjects Division, University of Washington
  • Geoffrey P. Lomax, Ph.D., Senior Officer, Standards Working Group, California Institute for Regenerative Medicine
  • Suzanne Vercauteren, Ph.D., Clinical Assistant Professor, Pathology and Laboratory Medicine, University of British Columbia
  • Dayong Gao, Ph.D., Professor, Mechanical Engineering and Bioengineering, University of Washington
  • Wendell G. Yarbrough, M.D., MMHC, FACS, Professor of Surgery, Otolaryngology and Pathology; Section Chief, Otolaryngology; Co-Director, Molecular Virology Research Program; Director, Head and Neck Cancer Program, Smilow Cancer Hospital, Yale University
  • Allison Hubel, Ph.D., Professor, Mechanical Engineering and Director, Biopreservation Core Resource, University of Minnesota
  • William H. Yong, M.D., Director, Brain Tumor Translational Resource; Professor, Surgical Pathology; Associate Professor, Pathology and Laboratory Medicine, Autopsy, Neuropathology, Brain Research Institute and David Geffen School of Medicine, University of California, Los Angeles
  • Stefano Begolo, Ph.D., Research Scientist, Rustem F. Ismagilov Laboratory, Division of Chemistry and Chemical Engineering, California Institute of Technology
  • Andrew Brooks, Ph.D., COO, Rutgers University Cell and DNA Repository; Associate Professor, Genetics, Rutgers University 

 

 
Deadline for Abstracts: ---
 
Registration: Register now
E-mail: kwaterman@healthtech.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.